Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5169356
Max Phase: Preclinical
Molecular Formula: C30H42ClF3N6O9S
Molecular Weight: 755.21
Associated Items:
ID: ALA5169356
Max Phase: Preclinical
Molecular Formula: C30H42ClF3N6O9S
Molecular Weight: 755.21
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)CNC(=O)CC[C@H](NS(=O)(=O)c1ccc(Cl)c(C(F)(F)F)c1)C(=O)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(N)=O)C(C)C
Standard InChI: InChI=1S/C30H42ClF3N6O9S/c1-15(2)12-21(27(44)38-25(16(3)4)28(45)40-11-5-6-22(40)26(35)43)37-24(42)14-36-23(41)10-9-20(29(46)47)39-50(48,49)17-7-8-19(31)18(13-17)30(32,33)34/h7-8,13,15-16,20-22,25,39H,5-6,9-12,14H2,1-4H3,(H2,35,43)(H,36,41)(H,37,42)(H,38,44)(H,46,47)/t20-,21-,22-,25-/m0/s1
Standard InChI Key: WONMZRKDYXHZOT-UEOMBKFZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 755.21 | Molecular Weight (Monoisotopic): 754.2375 | AlogP: 1.13 | #Rotatable Bonds: 17 |
Polar Surface Area: 234.17 | Molecular Species: ACID | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.21 | CX Basic pKa: | CX LogP: 0.87 | CX LogD: -2.58 |
Aromatic Rings: 1 | Heavy Atoms: 50 | QED Weighted: 0.13 | Np Likeness Score: -0.88 |
1. Tabuse H, Abe-Sato K, Kanazawa H, Yashiro M, Tamura Y, Kamitani M, Hitaka K, Gunji E, Mitani A, Kojima N, Oka Y.. (2022) Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1' Subsite Binder with Short Peptides., 65 (19.0): [PMID:36137271] [10.1021/acs.jmedchem.2c01088] |
Source(1):